Carina Namih: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Carina Namih works with emerging technologies to build social products. She cofounded HelixNano, an early-stage company at the intersection of software, genetics and synthetic biology. Her previous company, awarded for social innovation by the White House, enables circular integration of the electronics supply chain. She studied moral and political philosophy at Oxford, is a fellow of the RSA and an advisor to the upcoming Science Art Gallery London. She is a member of the NearNow design studio where her research concerns the proliferation of biosensing devices, and the emergence of an "Internet of Bodies". | Carina Namih works with emerging technologies to build social products. She cofounded HelixNano, an early-stage company at the intersection of software, genetics and synthetic biology. Her previous company, awarded for social innovation by the White House, enables circular integration of the electronics supply chain. She studied moral and political philosophy at Oxford, is a fellow of the RSA and an advisor to the upcoming Science Art Gallery London. She is a member of the NearNow design studio where her research concerns the proliferation of biosensing devices, and the emergence of an "Internet of Bodies". | ||
[[Internet of Bodies|Workshop about The Internet of Bodies]] | [[Internet of Bodies|Workshop about The Internet of Bodies]] with [[Simone Niquille]] | ||
Revision as of 13:39, 17 July 2016
Carina Namih works with emerging technologies to build social products. She cofounded HelixNano, an early-stage company at the intersection of software, genetics and synthetic biology. Her previous company, awarded for social innovation by the White House, enables circular integration of the electronics supply chain. She studied moral and political philosophy at Oxford, is a fellow of the RSA and an advisor to the upcoming Science Art Gallery London. She is a member of the NearNow design studio where her research concerns the proliferation of biosensing devices, and the emergence of an "Internet of Bodies".